期刊文献+

血管紧张素转化酶2激活预防肺动脉高压的实验研究 被引量:5

The preventive effect of ACE2 activation on the development of severe pulmonary arterial hypertension
暂未订购
导出
摘要 目的:探讨血管紧张素转化酶2(ACE2)激活,对肺叶切除联合野百合碱注射,诱导重度肺动脉高压(PAH)的预防作用。方法:左肺切除+野百合碱注射建立大鼠重度PAH模型。雄性SD大鼠50只,随机分为5组,A组为空白对照组、B组为Resorcinolnaphthalein(Res)对照组,C组为PAH组,D组为Res预防组,E组为Res+A-779干预组。测量平均肺动脉压力(mPAP)、右心室肥厚指数(RVHI);弹力纤维染色分析肺血管病变;ELISA、Western Blot分析肾素血管紧张素系统各主要成分的水平。结果:处理3 w后,C组大鼠mPAP、RVHI明显升高,出现了严重的肺动脉中膜肥厚、内膜增生(与A组比较,P<0.05),D组上述4项指标明显减轻(与C组比较,P<0.05);E组则比D组病变严重(P<0.05)。ACE、Ang-II及AT1R水平,D组明显低于C组(P<0.05),而ACE2、Ang-(1-7)及Mas水平D组明显高于C组(P<0.05)。结论:Res激活ACE2可以抑制重度肺动脉高压的形成,调节肾素血管紧张素系统的平衡,可能是其作用的主要机制之一。 Objective:To investigate the effect of angiotensin converting enzyme 2(ACE2) activation by resorcinolnaphthalein(Res) on the severe pulmonary arterial hypertension(PAH) in rats.Methods:The pulmonary arterial hypertension in rats was induced by monocrotaline injection one week following left pneumonectomy.Fifty male rats were randomly divided into five groups including control(Group A),Res-treated normal rats(Group B),PAH group(Group C),Res-treated PAH rats(Group D) and combined treated with Res and A-779 group(Group E).The mean pulmonary arterial pressure(mPAP),systolic arterial pressure,right ventricular hypertrophy index(RVHI),medial hypertrophy and neointimal formation in pulmonary arteries with different diameter and the levels of main renin-angiotensin-system components in lungs were examined in the rats.Results:Three weeks after the treatment,ACE2 activity increased in Group B when compared to Group A(P0.05),and the values in group D were higher than group C(P0.05).The rats in group C showed high mPAP,RVHI,severe medial hypertrophy and neointimal formation when compared to Group A(P0.05).These four index in group D were significantly lower than the values in group C(P0.05),but were not changed in Group E.Compared to group C,group D rats displayed lower levels of ACE,Angiotensin-II and AT1R(all P0.05),but higher levels of ACE2,angiotensin-(1-7) and Mas(all P0.05).Conclusion:Activation of ACE2 by Res continuous injection prevented the formation of severe PAH through mediating the balance among the components of renin-angiotensin-system.
出处 《心肺血管病杂志》 CAS 2012年第2期192-195,共4页 Journal of Cardiovascular and Pulmonary Diseases
基金 国家自然科学基金项目(30972958)
关键词 肺动脉高压 血管紧张素转化酶2 内膜增生 Pulmonary arterial hypertension Angiotensin converting enzyme 2 Neointimal formation
  • 相关文献

参考文献11

  • 1Li X,Molina-Molina M,Abdul-Hafez A,et al.Angiotensin con-verting enzyme-2 is protective but downregulated in human andexperimental lung fibrosis.Am J Physiol Lung Cell Mol Physiol,2008,295:L178-L185.
  • 2顾虹,卓玲,李强强,刘海菊,刘天洋,郭保静,张陈.西地那非在儿童先天性心脏病相关性肺动脉高压中的应用[J].心肺血管病杂志,2011,30(3):191-194. 被引量:9
  • 3Imai Y,Kuba K,Rao S,et al.Angiotensin-converting enzyme 2protects from severe acute lung failure.Nature,2005,436:112-116.
  • 4Iwai M,Horiuchi M.Devil and angel in the renin-angiotensinsystem:ACE-angiotensin II-AT1 receptor axis vs ACE2-angioten-sin-(1-7)-Mas receptor axis.Hypertens Res,2009,32:533-536.
  • 5Shenoy V,Qi Y,Katovich MJ,et al.ACE2,a promising thera-peutic target for pulmonary hypertension.Curr Opin Pharmacol,2011,11:150-155.
  • 6张颖,刘双,朱光发,杨京华,何建国.西地那非治疗肺动脉高压的临床疗效观察[J].心肺血管病杂志,2011,30(1):20-24. 被引量:24
  • 7Okada K,Tanaka Y,Bernstein M,et al.Pulmonary hemody-namics modify the rat pulmonary artery response to injury.Aneointimal model of pulmonary hypertension.Am J Pathol,1997,151:1019-1025.
  • 8王振兴,陈静瑜,郑明峰,何毅军,卫栋,吴波.肺移植治疗儿童肺动脉高压的临床疗效[J].中华胸心血管外科杂志,2011,27(10):597-600. 被引量:3
  • 9Farber HW,Loscalzo J.Pulmonary arterial hypertension.N E JM,2004,351:1655-1665.
  • 10Bradford CN,Ely DR,Raizada MK.Targeting the vasoprotectiveaxis of the renin-angiotensin system:a novel strategic approach topulmonary hypertensive therapy.Curr Hypertens Rep,2010,12:212-219.

二级参考文献33

共引文献32

同被引文献51

  • 1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:121
  • 2荆志成.我国肺动脉高压专家共识阐释[J].中国实用内科杂志,2007,27(4):246-249. 被引量:56
  • 3魏来,赵强,陈安清,陆军,姚瑞明,贾剑国,王克强,邹云增.右侧全肺切除致大鼠动力型肺动脉高压模型的建立[J].中国临床医学,2007,14(4):482-484. 被引量:5
  • 4Stenmark KR, McMurtry IF. Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal?. Circ Res, 2005,97(2) :95-98.
  • 5Okada K, Tanaka Y, Bernstein M, et al. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol, 1997,151 (4) :1019-1025.
  • 6Lepetit H, Eddahibi S, Fade1 E, et al. Sm Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J, 2005,25 (5) :834-842.
  • 7Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med, 2004,351 (16) : 1655-1665.
  • 8Takahashi H, Goto N, Kojima Y, et al. Downregulation of type II bone morphogentic protein receport in hypoxic pulmonary hypertension. Am J Physiol Lung Cell M01 Physiol, 2006,290(3 ) : L450-458.
  • 9Chen L, Xiao J, Li Y, et al. Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats. Eur Rev Med Pharmacol Sci, 2011,15 ( 1 ) : 1 - 7.
  • 10Molteni A, Wmxt WF, Ts'ao CH, et al. Monocrotaline-induced pulmonary endothelial dysfunction in rats. Proc Soc Exp Biol Med, 1984,176( 1 ) :88-94.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部